Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma

Introduction The role of the adaptive immune system in the pathophysiology of cancer-associated venous thromboembolism (VTE) has not been investigated in detail. Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule responsible for immune evasion in several cancer entities, as expr...

Full description

Bibliographic Details
Main Authors: Matthias Preusser, Christine Marosi, Anna S Berghoff, Florian Moik, Ingrid Pabinger, Cihan Ay, Pegah Mir Seyed Nazari, Florian Posch, Gerda Ricken, Julia Riedl, Lena Hell, Johannes A Hainfellner
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/3/e000647.full

Internet

https://esmoopen.bmj.com/content/5/3/e000647.full

Similar Items